• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Blogs
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Blogs
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    What Women Want: Clean, Transparent & Personalized Products

    Demand for Protein Propels Market Diversity & Product Innovation

    The Future of Nutraceuticals Packaging

    Swisse Wellness Adopts Unique Label, Branded Desiccant to Protect Product Authenticity

    Consumers Seek Added Nutritional Boost from Antioxidants
    Blogs & Guest Articles
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Live From Shows
    Top News
    Compounds in Grapes, Dark Chocolate, Coffee, & Blueberries May Treat Depression

    Research Finds Fatty Fish and Camelina Oil Benefit Cholesterol

    Industry Interest in Nutrigenomics is Growing

    Omax Health Unveils Alpha & Omega Cognitive Boost

    Study Examines Vitamin K2 Content in Cheese
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Research Finds Fatty Fish and Camelina Oil Benefit Cholesterol

    Omax Health Unveils Alpha & Omega Cognitive Boost

    Study Examines Vitamin K2 Content in Cheese

    Probi Probiotics Show Benefits for Bone Health

    Study Questions Omega-3's Benefits for Dry Eye
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Compounds in Grapes, Dark Chocolate, Coffee, & Blueberries May Treat Depression

    Research Finds Fatty Fish and Camelina Oil Benefit Cholesterol

    Industry Interest in Nutrigenomics is Growing

    Omax Health Unveils Alpha & Omega Cognitive Boost

    Study Examines Vitamin K2 Content in Cheese
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Compounds in Grapes, Dark Chocolate, Coffee, & Blueberries May Treat Depression

    Research Finds Fatty Fish and Camelina Oil Benefit Cholesterol

    Omax Health Unveils Alpha & Omega Cognitive Boost

    Study Examines Vitamin K2 Content in Cheese

    Probi Probiotics Show Benefits for Bone Health
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    Add New Company
    International Buyers Guide Companies
    Sigachi US Inc.

    Global Curcumin Association

    Consumer Product Testing Co., Inc.

    Aker BioMarine

    Marcor, an Azelis Company
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Stepan Lipid Nutrition

    PLT Health Solutions

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
      • Add Your Company
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    Proprietary Perspectives: Ephedra: Eclipse, Macroeconomics And Enigma

    Sorting out the ephedra controversy.

    Related CONTENT
    • Proprietary Perspective: Borrowed Science Or Data Piracy?
    • Proprietary Perspective: Science Faction
    • Proprietary Perspective: The "Elusiveness" of Synergy
    • Proprietary Perspective: Antioxidants Autobiography
    • Proprietary Perspective: Collaborative Conundrum
    Anthony L. Almada07.01.01

    Ephedra: Eclipse, Macroeconomics And Enigma



    Sorting out the ephedra controversy.



    By Anthony L. Almada



    What dost thou sayeth—Ephedrine, prime mover of the genus Ephedra, fruit of its root, is friend to thine heart and foil to thine indulgences seen in thy growing flesh? Ye companies of cetacean size, what of thine economic health if the Ephedra sun is eclipsed by the dark moon of the lords of feast and medicines? What haveth thou that can fill the shadow of this omnipresent potion? How can thee assume this daughter of d-amphetamine is safe for ALL, even those presumeth to be “healthy”? With thine nation’s masses consuming thy fatness nemesis is it not inevitable that one of thine own children shall suffer an effectus adverseth?

    My anemic attempts to produce Shakespearean rhetoric utterly crumble in the face of the Ephedra enigma. The line of battle lies within our industry; the internecine war of the naturalists and the industrialists has been waged since the “ephedra as stimulant trend” was born in the mid to late 1980s, driven by a now defunct company called Excel. Then emerged the “Pep” line, fueling new growth and a new type of diet products—in a solid dosage form “au naturel,” positioned against phenylpropanolamine (PPA), which happens to be a minor constituent of Ephedra extracts. Not until 1991 was the “thermogenic” badge affixed to Ephedra + caffeine combinations by KAL and a new category of products slipstreamed behind.

    Companies have emerged out of the shopping mall, e.g. Metabolife, with enormous sales volumes spinning axially around this omnipotent plant. Other companies rest on the economic precipice, cliffhanging by the still intact but tenuous strength of the ephedra umbilical cord. Ephedra now appears in the delivery vehicle called chewing gum (which, based upon some research presented earlier this year with a caffeine-containing chewing gum, may increase the rate and amount of ephe­drine absorbed into the circulation). If ephedra was to be restricted from over the counter sale who would survive?

    Is it unlikely that President Bush will authorize an economic impact report investigating the fallout that would ensue if the FDA chose to ban ephedra from OTC use in combination with caffeine? The sounds of falling stock prices, century-scale layoffs and consumer outcry would be deafening. If ephedra-containing products enjoyed national sales volumes of, say, less than $10 million in all channels, yet the number of adverse events associated and assigned to them was no different than the hundreds that exist today, would the FDA already have pulled it off the market by its roots?

    Many of the naturalists quietly denounce the idea of ephedra being used as a stimulant and appetite suppressant/thermogenic. “It is a radical departure from the traditional, historical use of the plant. It bastardizes the traditional use developed by Oriental medicine and its practitioners. It drains the adrenals,” they say. Mind you, there appear to be NO studies anywhere in the world describing adrenal insufficiency/collapse among ephedra/ephedrine users, at least using Occidental measurement tools. With religious fervor these naturalists reserve ephedra for use with respiratory symptoms, to stimulate the heart and mind or as an anti-allergic. Who is to say they are incorrect?

    Many of the industrialists espouse the idea of ephedra being used as a stimulant and appetite suppressant/thermogenic. “When properly used it is safe and more effective than the prescription drugs used to treat obesity. Many studies document its safety and efficacy, for periods up to one year or greater. As a jump-start, many individuals benefit from the effects of Ephedra + caffeine. They don’t need to take it for a protracted amount of time. It has kept many companies in our industry off the resuscitator,” they say. The first original research study evaluating the safety and efficacy of ephedra + caffeine combos was published just this March (Int J Obes). The second study was presented only this April, using only ephedra + caffeine (Kola nut) (Experimental Biology, Orlando, FL). Who’s to say the industrialists are incorrect?

    Of the naturalists who advocate botanical extracts as superior to pure chemicals, they have no leg (or branch) to stand on when it comes to ephedra-delivered ephedrine versus laboratory “grown” (synthetic) ephedrine. The comparison trials examining safety and efficacy do not exist. Synthetic ephedrine, if present as the “racemic” dl mixture, or as d-ephedrine (ephedra that has not been adulterated contains only l-ephedrine), may be less prone to produce adverse events and more likely to elicit appetite suppressant and body fat reducing effects. Warner-Lambert has an “improvement” patent on this exact use, although it is questionable if it ever will be transferred to a live product.

    What many fail to acknowledge on both sides of the battlefield is that only a few studies have been done with ephedra + caffeine examining safety and efficacy. ALL of the previously published studies on the topic used synthetic ephedrine + caffeine, with a 1:10 ratio seeming to be superior. The first study, which used Metabolife-356® as the test agent (delivering 63 mg of ephe­drine and 300 mg of caffeine/day, verified by chemical analysis), saw eight of the 35 subjects receiving this product drop out because of adverse effects. However, those that did endure the stimulant effects saw a loss of 7.7 pounds of body fat after eight weeks, compared to the placebo group, which saw only 1.5 pounds vanish.

    In the second investigation, done by the same research group but with SIX MONTHS of supplementation, only about HALF of all the subjects completed the study. The test product here was a generic blend of ephedra (90 mg ephedrine/day) and 192 mg caffeine/day from kola nut (which happens to harbor other bioactive and potentially fat-relevant compounds). In this study, weight and fat loss again were far superior with the ephedra + caffeine combo yet only blood pressure was elevated throughout the study in this group, in comparison to the placebo group. This far more rigorous study found the product to overall be well tolerated, equally well tolerated in comparison to placebo and lacking adverse effects of concern.

    Consumers seem to have ignored the media warnings over ephedra; sales remain strong and new brands emerge like wildflowers in spring. The attempt by some to introduce a safer ephedra “alternative” appears to be ineffectual. The marketing push behind Citrus aurantium extract, bearer of synephrine, lack proof of concept data in humans when administered alone and consumers do not appear wishful of swallowing the bitter orange pill in place of ephedra. The entity/person that does identify and validate an ephedra + caffeine blend with long-term safety (read phase IV/pharmacosurveillance studies) and/or a “substitute” for ephedra with equal efficacy, shall be a richer woman or man.NW
    Related Searches
    • Quality & Safety
    • Skin Health
    • Healthcare Trends
    Related Knowledge Center
    • Healthcare Trends
    • Skin Health
    • Quality & Safety
    Suggested For You
    Understanding FTC Standards for Claims Substantiation Understanding FTC Standards for Claims Substantiation
    Transforming Health with Nature’s Sunshine Transforming Health with Nature’s Sunshine
    TREHA Trehalose Available As ‘Natural Flavor’ TREHA Trehalose Available As ‘Natural Flavor’
    ConsumerLab.com Tests Popular Vitamin D Supplements ConsumerLab.com Tests Popular Vitamin D Supplements
    Gottlieb Confirmed to Lead FDA Gottlieb Confirmed to Lead FDA
    Green Tea + Vitamin D3 Green Tea + Vitamin D3
    Word from Wall Street: The Latest Acquisitions Word from Wall Street: The Latest Acquisitions
    Word from Wall Street: A Roll-Up in the Making Word from Wall Street: A Roll-Up in the Making
    Proprietary Perspectives: It Branded Me With Science Proprietary Perspectives: It Branded Me With Science
    Proprietary Perspectives: Dysfunctional Beverages Proprietary Perspectives: Dysfunctional Beverages
    Proprietary Perspective: Collaborative Conundrum Proprietary Perspective: Collaborative Conundrum
    Proprietary Perspective: Antioxidants Autobiography Proprietary Perspective: Antioxidants Autobiography
    Proprietary Perspective: The "Elusiveness" of Synergy Proprietary Perspective: The "Elusiveness" of Synergy
    Proprietary Perspective: Science Faction Proprietary Perspective: Science Faction
    Proprietary Perspective: Borrowed Science Or Data Piracy? Proprietary Perspective: Borrowed Science Or Data Piracy?

    Related Columns

    • Dietary Supplements | Healthcare Trends | Medical Nutrition
      Corporate Titans Enter the  Practitioner Channel: Prepare for Disruption

      Corporate Titans Enter the Practitioner Channel: Prepare for Disruption

      Status quo business models that have been operative in healthcare for decades are not likely to remain status quo for long.
      By Erik Goldman, Holistic Primary Care 03.01.18

    • Dietary Supplements | Healthcare Trends
      Product Liability Insurance Rates Continue Steep Decline

      Product Liability Insurance Rates Continue Steep Decline

      With dangerous coverage exclusions still lurking, thorough coverage analysis remains important.
      By Greg Doherty, Bolton & Company 03.01.18

    • Herbs & Botanicals | Quality & Safety
      Standardization & Equivalence in Herbal Medicines

      Standardization & Equivalence in Herbal Medicines

      Reliable and consistent quality is the basis for efficacy and safety of herbal medicinal products.
      By Dilip Ghosh, PhD, FACN, nutriConnect 03.01.18


    • Healthcare Trends | Medical Nutrition
      Expect Changes for the Nutraceutical Industry in the Year Ahead

      Expect Changes for the Nutraceutical Industry in the Year Ahead

      To succeed in a complex, emerging environment, don’t react; be the agent of change.
      By Gregory Stephens, Windrose Partners 01.05.18

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Healthy Aging | Medical Nutrition | Quality & Safety | Regulations
      Who Will Care for Generation ‘Octo’?

      Who Will Care for Generation ‘Octo’?

      Aware the social and medical safety net is full of holes, today’s seniors recognize the need to self-manage their own health.
      By Erik Goldman, Holistic Primary Care 12.04.17

    • Dietary Supplements | Healthcare Trends | Quality & Safety | Regulations
      Celebrity Endorsements: Protecting Your Brand

      Celebrity Endorsements: Protecting Your Brand

      Pitfalls abound; smart insurance and legal advice is required upfront.
      By Greg Doherty, Bolton & Company 12.04.17


    • Antioxidants | Dietary Supplements | Herbs & Botanicals | Quality & Safety | Research
      What’s Brewing in Herbal Tea?

      What’s Brewing in Herbal Tea?

      More consumers are opting for herbal teas that offer diverse biological properties.
      By Dilip Ghosh, PhD, FACN, Nutriconnect 12.04.17

    • Dietary Supplements | Healthcare Trends | Regulations
      When a Patent Is Not Enough: Product Commercialization Considerations

      When a Patent Is Not Enough: Product Commercialization Considerations

      A comprehensive intellectual property strategy can help assure successful commercialization.
      By Gregory Stephens & Marina Volin, Esq., Windrose Partners 11.01.17

    • Dietary Supplements | Healthcare Trends | Medical Nutrition | Regulations
      Medical Foods Regulation: FDA’s Restrictive View Stifles Innovation

      Medical Foods Regulation: FDA’s Restrictive View Stifles Innovation

      The present regulatory scheme is out of date and requires significant revisions to reflect modern realities.
      By Todd Harrison, Venable 11.01.17


    • Dietary Supplements | Herbs & Botanicals | Quality & Safety
      AHPA Supports Appalachian Beginning Forest Farmer Coalition (ABFFC)

      AHPA Supports Appalachian Beginning Forest Farmer Coalition (ABFFC)

      Forest farming of native woodland medicinal plants allows for increased quality control and traceability.
      By Maged Sharaf, PhD, American Herbal Products Association (AHPA) 11.01.17

    • Dietary Supplements | Quality & Safety | Regulations
      Big Retail’s Trend Toward Higher Product Liability Insurance Requirements

      Big Retail’s Trend Toward Higher Product Liability Insurance Requirements

      Supplement companies struggle with higher premium costs to satisfy the giants of retail.
      By Greg Doherty, Bolton & Company 10.02.17

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Infant & Children's Health | Mood Health & Sleep
      Herb-Nutra Psychiatry:  Adjunctive Treatments for ADHD

      Herb-Nutra Psychiatry: Adjunctive Treatments for ADHD

      Solutions derived from natural sources may help manage or treat this complex disorder.
      By Dilip Ghosh, PhD, FACN, nutriConnect 10.02.17

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Medical Nutrition
      Grow Your Nutritional Business through Effective Market Research

      Grow Your Nutritional Business through Effective Market Research

      Experts offer advice for developing a well-informed market research plan that addresses your goals.
      By Gregory Stephens, Windrose Partners, & Jim Dorsch 09.07.17

    • Contract Manufacturing | Dietary Supplements | Quality & Safety | Regulations
      Current Good Manufacturing Practices & the Private-Label Distributor

      Current Good Manufacturing Practices & the Private-Label Distributor

      PLDs are responsible for products introduced into interstate commerce and must ensure compliance with federal requirements.
      By Todd Harrison, Venable 09.07.17

    • Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Regulations | World Markets
      De-Harmonization Complicates Market Access to Europe

      De-Harmonization Complicates Market Access to Europe

      A lack of health claims and upper limits for vitamins and minerals has affected innovation and business.
      By Joerg Gruenwald, analyze & realize ag 09.07.17

    Breaking News
    • P&G Acquires Merck KGaA’s Consumer Health Business
    • Compounds in Grapes, Dark Chocolate, Coffee, & Blueberries May Treat Depression
    • Research Finds Fatty Fish and Camelina Oil Benefit Cholesterol
    • Industry Interest in Nutrigenomics is Growing
    • DSM Opens Seven-Acre Solar Field
    View Breaking News >
    CURRENT ISSUE

    April 2018

    • Demand for Protein Propels Market Diversity & Product Innovation
    • The Future of Nutraceuticals Packaging
    • Swisse Wellness Adopts Unique Label, Branded Desiccant to Protect Product Authenticity
    • What Women Want: Clean, Transparent & Personalized Products
    • View More >

    Copyright © 2018 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.